Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Results
Phase 3
This trial compared a drug called ofatumumab with other standard treatments for chronic lymphocytic leukaemia.
It was for people who had:
leukaemia that had got worse or come back despite having fludarabine
swollen
Recruitment start: 1 August 2011
Recruitment end: 27 March 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Anna Schuh
Genmab
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 6 November 2018
CRUK internal database number: 8234
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
